NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.82+0.03 (+3.89%)
Close on Nov 17, 2026Market cap $94.88MP/E –Yield –
NovaBridge Biosciences total assets
Total assets on the balance sheet at the end of each period.
NovaBridge Biosciences's total assets was CN¥2.61B at Dec 31, 2023. For fiscal 2023 it was CN¥2.61B, down 35.9% from the year before. The highest annual figure on record is CN¥6.33B in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | CN¥2.61B | -35.9% |
| FY2022 | Dec 31, 2022 | CN¥4.07B | -27.3% |
| FY2021 | Dec 31, 2021 | CN¥5.60B | -11.6% |
| FY2020 | Dec 31, 2020 | CN¥6.33B | +264.5% |
| FY2019 | Dec 31, 2019 | CN¥1.74B | -26.9% |
| FY2018 | Dec 31, 2018 | CN¥2.38B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | CN¥2.61B | -58.7% |
| Q4 FY2022 | Dec 31, 2022 | CN¥4.07B | -5.2% |
| Q2 FY2022 | Jun 30, 2022 | CN¥4.99B | +187.3% |
| Q4 FY2021 | Dec 31, 2021 | CN¥5.60B | +135.7% |
| Q4 FY2020 | Dec 31, 2020 | CN¥6.33B | – |
| Q3 FY2020 | Sep 30, 2020 | CN¥4.30B | – |
| Q4 FY2019 | Dec 31, 2019 | CN¥1.74B | – |
| Q4 FY2018 | Dec 31, 2018 | CN¥2.38B | – |
See a number that looks wrong?